Claim · claimSorter/cs-058

Ibogaine is the most effective single-session treatment for opioid use disorder currently known

Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.

Ibogaine is the most effective single-session treatment for opioid use disorder currently known

Unresolved recorded as “Not Established; Early Uncontrolled Data” Plants of the Gods

Stanford study (Cherian et al., Nature Medicine, 2024, n=30 veterans with traumatic brain injury, open-label with no control group): large improvements in PTSD, depression and anxiety at 1-month follow-up; it did not study opioid use disorder. Observational studies (for example Noller et al., 2018; Davis et al., Journal of Psychedelic Studies, 2017) report reduced opioid use after ibogaine, without control groups. But: no Phase 3 RCT has been completed; cardiac safety (ibogaine prolongs QT interval) requires controlled administration; standard medications for opioid use disorder have strong trial evidence that ibogaine does not yet have. The claim may be true; the evidence base is Phase 2.